220 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
remit such amounts to Fennec.
Reports and Records; Audit by Fennec. Licensee shall keep (and shall cause its Affiliates to keep) accurate books … under this Agreement; provided however, that the books and records for any particular calendar year will only be subject to one audit. Licensee shall
8-K/A
EX-99.1
FENC
Fennec Pharmaceuticals Inc
6 Mar 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:07pm
closing procedures and year end audit.
Preliminary Unaudited 2023 Fourth Quarter Revenue and Year End Performance:
Fourth quarter 2023 net revenues
8-K
EX-99.1
6ou kvsa4dmspvnm
29 Feb 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:04pm
8-K
m68pkfp36cpgkvw5fi
29 Feb 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:04pm